Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
about
Ovarian cancer epidemiology in the era of collaborative team science.Major clinical research advances in gynecologic cancer in 2016: 10-year special edition.Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300 000 Norwegian women.Epidemiology of ovarian cancer: a review.Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer.Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium.Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium.Tubal ligation and ovarian cancer risk in African American women.Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES).Examining the common aetiology of serous ovarian cancers and basal-like breast cancers using double primaries.International patterns and trends in ovarian cancer incidence, overall and by histologic subtype.Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.Hormonal and reproductive factors and the risk of ovarian cancer.Two sisters with Mayer-Rokitansky-Küster-Hauser syndrome and serous adenocarcinoma of the ovary.Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer.Ovarian Cancer Prevention in High-risk Women.Challenges and Opportunities in Studying the Epidemiology of Ovarian Cancer Subtypes.Third Trimester Estrogens and Maternal Breast Cancer: Prospective Evidence.Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study.Lifestyle and Reproductive Factors and Ovarian Cancer Risk by p53 and MAPK Expression.The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers.Epidemiologic paradigms for progress in ovarian cancer research.Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.Does an epidemiological comparison support a common cellular lineage for similar subtypes of postmenopausal uterine and ovarian carcinoma? The Norwegian Women and Cancer Study.Migraine and invasive epithelial ovarian cancer risk in the Nurses' Health Study II and the Women's Health Study.Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors.Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.Chlamydia trachomatis, Chlamydial Heat Shock Protein 60 and Anti-Chlamydial Antibodies in Women with Epithelial Ovarian Tumors.Histopathological Pattern and Age Distribution, of Malignant Ovarian Tumor among Sudanese Ladies.Recent Insights into Mucinous Ovarian Carcinoma.Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women
P2860
Q30252987-3E2F0B04-E8F5-47F2-A1BC-087D88D563A0Q33563963-8F5F2310-C256-4F27-A547-24EB9E030E0DQ37592890-08B1F500-E3F7-4B5B-9F9E-BF4CECCC1C0EQ37720438-E511FC0E-5B5D-415B-8FAD-D60841E747C9Q38756382-3134052D-9893-4970-8FCC-5B7F0BBB298BQ38756834-0B161A1C-8E06-4678-9049-31C84FDFB76EQ38851593-022CDF2D-EA95-4CBB-B5DE-F34D8321477EQ40058118-F0341D90-49B0-4A36-9DB1-83B72F5F7C13Q40217839-61271893-D6B9-4578-BBC5-24CD3CADB014Q40277712-F0AE7D6D-205E-40B4-B2CE-ACD3D96D8AFEQ40309521-6594830A-11F8-4360-87F6-8BAE22657F95Q40332287-AA40BB4E-8C6B-4D90-A086-555B55FC2BE2Q40373667-355F315D-0F7F-4E2A-9B4B-3A2E59D55D14Q41180126-F3E14263-0DBF-4B7C-B25C-816950B71070Q42369233-16328B7A-F092-4CAA-B841-A5289038C1C5Q45068704-489B6F50-6112-4101-9B99-AB818FE4D3CCQ45933729-2B630E8D-C9B7-4369-AAD7-D73EDE7E2E85Q46117451-3ECCDF4C-107A-47F7-A3BF-93E9A8EB9CB2Q47158663-BA86C28C-514B-41CF-A8AF-BDAFDF367299Q47407277-EBDA55B1-B93F-45A7-9BCC-D11C6968AE33Q47560912-144EEFD7-83B8-4E1B-8521-42867FE0C367Q47583338-E1096855-DE6C-481E-96A8-99B327CE6A11Q48110433-411B4321-DF53-44B3-8481-7436E0E98901Q48308633-D4DA9F9B-B05C-46B5-A868-A448D0BBD089Q50001028-5543E623-4516-44F0-81DD-CF4FB48C4D5CQ50334520-6234B690-B231-4655-B789-90506F45B638Q52759419-7D90BBD6-D622-4A03-BC36-40D9CEE3D8E3Q53177289-3FB0FB2C-358A-4B45-B001-C1822FE5CF28Q53838108-1D2AA314-691F-4D66-A473-F515A1C6A314Q55609057-9E7731F3-B296-4591-A614-155CD3AE5314Q57463812-11585A18-9255-4366-8186-1AC2840F347F
P2860
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Ovarian Cancer Risk Factors by ...... rian Cancer Cohort Consortium.
@en
Ovarian Cancer Risk Factors by ...... rian Cancer Cohort Consortium.
@nl
type
label
Ovarian Cancer Risk Factors by ...... rian Cancer Cohort Consortium.
@en
Ovarian Cancer Risk Factors by ...... rian Cancer Cohort Consortium.
@nl
prefLabel
Ovarian Cancer Risk Factors by ...... rian Cancer Cohort Consortium.
@en
Ovarian Cancer Risk Factors by ...... rian Cancer Cohort Consortium.
@nl
P2093
P2860
P50
P356
P1476
Ovarian Cancer Risk Factors by ...... rian Cancer Cohort Consortium.
@en
P2093
Alan A Arslan
Alpa V Patel
Amanda Black
Annika Idahl
Britton Trabert
Catherine Schairer
Elizabeth M Poole
Emily White
Hannah P Yang
P2860
P304
P356
10.1200/JCO.2016.66.8178
P407
P50
P577
2016-06-20T00:00:00Z